Cancers: Molecular Imaging and Therapy
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Methods and Technologies Development".
Deadline for manuscript submissions: closed (25 January 2024) | Viewed by 6284
Special Issue Editor
2. Department of Radiology, Duke University, Durham, NC 27708, USA
Interests: molecular imaging and therapy; positron emission tomography; cancer care inequities
Special Issue Information
Dear Colleagues,
We are pleased to announce a new Special Issue entitled ‘Molecular Imaging and Therapy’, to be published in Cancers, comprising a collection of articles from leading international experts on positron emission tomography/computed tomography (PET/CT) and radiopharmaceutical therapies for human solid tumours/cancers. The field of ‘Theranostics’, which is based on diagnostic and therapeutic radiopharmaceutical agents, is transforming the landscape of oncological imaging, promoting the development of treatments outside of conventional surgery/chemotherapy/radiation therapy and improving patient outcomes. This Special Issue aims to provide an updated overview of the evolving field of theranostics and discuss novel biomarkers, therapy approaches, opportunities and challenges in this exciting field encompassing cancer biology, imaging and therapy.
Prof. Dr. Subramaniam Rathan
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- PET/CT
- theranostics
- prostate cancer
- neuroendocrine tumors
- 68Ga FAPI
- 68Ga DOTATATE /18F DOTATATE
- 68Ga PSMA /18F PSMA
- 177Lu DOTATATE / 177Lu PSMA
- 225Ac DOTATATE / 222Ac PSMA